Pulmonary: |
|
|
|
Lower Respiratory Tract Infection [no. (%)] |
31 (46%) |
44 (38%) |
0.352 |
URTI [no. (%)] |
5 (7%) |
2 (2%) |
0.103 |
Croup [no. (%)] |
2 (3%) |
15 (13%) |
0.032 |
Asthma exacerbation [no. (%)] |
3 (4%) |
7 (6%) |
0.747 |
Apnea [no. (%)] |
0 (0%) |
1 (1%) |
1.000 |
Inflammatory: |
|
|
|
Fever [no. (%)] |
6 (9%) |
5 (4%) |
1.000 |
MIS-C [no. (%)] |
2 (3%) |
3 (3%) |
1.000 |
Neonatal Fever/Sepsis Workup [no. (%)] |
6 (9%) |
9 (8%) |
0.787 |
Cardiac: |
|
|
|
Cardiac arrest [no. (%)] |
0 (0%) |
2 (2%) |
0.532 |
Myo/pericarditis [no. (%)] |
0 (0%) |
2 (2%) |
0.532 |
Neurologic: |
|
|
|
TIA/Stroke [no. (%)] |
1 (1%) |
1 (1%) |
1.000 |
Aseptic meningitis [no. (%)] |
0 (0%) |
1 (1%) |
1.000 |
Seizure, including febrile seizure [no. (%)] |
3 (3%) |
9 (8%) |
0.540 |
Altered mental status [no. (%)] |
1 (1%) |
0 (0%) |
0.370 |
Gastrointestinal: |
|
|
|
Gastroenteritis [no. (%)] |
7 (10%) |
18 (16%) |
0.378 |
DKA [no. (%)] |
5 (7%) |
1 (1%) |
0.027 |
Dehydration/FTT [no. (%)] |
5 (7%) |
0 (0%) |
0.006 |
Other: |
|
|
|
Inflammatory rash/urticaria [no. (%)] |
1 (1%) |
2 (2%) |
1.000 |
Mucositis [no. (%)] |
0 (0%) |
1 (1%) |
1.000 |
Rhabdomyolysis/myositis [no. (%)] |
2 (3%) |
2 (2%) |
0.627 |
Acute chest crisis (in sickle cell disease) [no. (%)] |
0 (0%) |
3 (3%) |
0.297 |
Vaso-occlusive crisis [no. (%)] |
1 (1%) |
2 (2%) |
1.000 |
Vaginal bleeding [no. (%)] |
0 (0%) |
1 (1%) |
1.000 |
Immune-mediated thrombocytopenia [no. (%)] |
0 (0%) |
1 (1%) |
1.000 |
Chemotherapy complication [no. (%)] |
0 (0%) |
2 (2%) |
0.532 |
Intra-uterine fetal demise [no. (%)] |
1 (1%) |
0 (0%) |
0.370 |
Premature labor [no. (%)] |
1 (1%) |
1 (1%) |
1.000 |